Related Experiment Video
Updated: May 26, 2026
10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Epigenetic-based therapies in cancer: progress to date
Sang-Hyun Song1, Sae-Won Han, Yung-Jue Bang
1Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Drugs
|December 7, 2011
Summary
Epigenetic gene silencing in cancer involves DNA methylation and histone modification. Inhibiting DNA methyltransferases (DNMTs) and histone deacetylases (HDACs) shows promise in cancer therapy, with ongoing clinical trials exploring their effectiveness.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Epigenetic gene silencing, including DNA methylation and histone modification, is a key feature of cancer.
- DNA methyltransferases (DNMTs) and histone deacetylases (HDACs) catalyze these modifications, leading to gene inactivation.
- Inhibition of DNMTs and HDACs can induce cancer cell differentiation or apoptosis, making them attractive therapeutic targets.
Purpose of the Study:
- To review current advances in epigenetic therapies for cancer.
- To focus on recently reported clinical trials involving DNMT and HDAC inhibitors.
- To discuss the therapeutic potential and future challenges of epigenetic cancer treatments.
Main Methods:
- Review of recent clinical trials and molecular mechanisms of epigenetic therapies.
- Focus on hypomethylating agents and HDAC inhibitors.
- Analysis of anti-cancer effects induced by DNMT and HDAC inhibition.
Main Results:
- Numerous DNMT and HDAC inhibitors have been developed, with identified anti-cancer mechanisms.
- Ongoing clinical trials suggest hypomethylating agents and HDAC inhibitors are promising for various cancers.
- Effective combination strategies of epigenetic therapy with conventional chemotherapy represent a future challenge.
Conclusions:
- Epigenetic therapies targeting DNMTs and HDACs are advancing rapidly.
- Clinical trials indicate significant potential for hypomethylating agents and HDAC inhibitors in cancer treatment.
- Future research should focus on optimizing combination therapies for enhanced efficacy.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...